alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 72, Number 98 (Tuesday, May 22, 2007)]
[Notices]
[Page 28705]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-2544]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institutes of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel, ZEB1 OSR-C (01) R Quantum 
Grants 2007 Review.
    Date: June 19-20, 2007.
    Time: 8 a.m. to 1 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Marriott Bethesda North Hotel & Conference Center, 5701 
Marinelli Rd., North Bethesda, MD 20852.
    Contact Person: Prabha L. Atreya, PhD, Scientific Review 
Administrator, Office of Scientific Review, National Institute of 
Biomedical Imaging and Bioengineering, Bethesda, MD 20892, (301) 
496-8633, <a href="/cdn-cgi/l/email-protection#dabbaea8bfa3bbaaa89ab7bbb3b6f4b4b3b2f4bdb5ac"><span class="__cf_email__" data-cfemail="a1c0d5d3c4d8c0d1d3e1ccc0c8cd8fcfc8c98fc6ced7">[email protected]</span></a>.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel, ZEB1 OSR-B (01) S Training 
and Career Award Review.
    Date: July 12, 2007.
    Time: 8 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Ruixia Zhou, PhD, Scientific Review 
Administrator, 6707 Democracy Boulevard, Democracy Two Building, 
Suite 957, Bethesda, MD 20892, (301) 496-4773, <a href="/cdn-cgi/l/email-protection#a0dac8cfd5d2e0cdc1c9cc8ecec9c88ec7cfd6"><span class="__cf_email__" data-cfemail="0f7567607a7d4f626e66632161666721686079">[email protected]</span></a>.

    Dated: May 15,2007.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-2544 Filed 5-21-07; 8:45 am]
BILLING CODE 4140-01-M


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
[Federal Register Volume 72, Number 115 (Friday, June 15, 2007)]
[Presidential Documents]
[Page 33381]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-3005]



[[Page 33379]]

-----------------------------------------------------------------------

Part V





The President





-----------------------------------------------------------------------



Notice of June 14, 2007--Continuation of the National Emergency 
Blocking Property of Certain Persons Undermining Democratic Processes 
or Institutions in Belarus


                        Presidential Documents 



Federal Register / Vol. 72, No. 115 / Friday, June 15, 2007 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 33381]]

                Notice of June 14, 2007

                
Continuation of the National Emergency Blocking 
                Property of Certain Persons Undermining Democratic 
                Processes or Institutions in Belarus

                On June 16, 2006, by Executive Order 13405, I declared 
                a national emergency and ordered related measures 
                blocking the property of certain persons undermining 
                democratic processes or institutions in Belarus, 
                pursuant to the International Emergency Economic Powers 
                Act (50 U.S.C. 1701-1706). I took this action in 
                response to the unusual and extraordinary threat to the 
                national security and foreign policy of the United 
                States constituted by the actions and policies of 
                certain members of the Government of Belarus and other 
                persons that have undermined democratic processes or 
                institutions; committed human rights abuses related to 
                political repression, including detentions and 
                disappearances; and engaged in public corruption, 
                including by diverting or misusing Belarusian public 
                assets or by misusing public authority.

                Because these actions and policies continue to pose an 
                unusual and extraordinary threat to the national 
                security and foreign policy of the United States, the 
                national emergency declared on June 16, 2006, and the 
                measures adopted on that date to deal with that 
                emergency, must continue in effect beyond June 16, 
                2007. Therefore, in accordance with section 202(d) of 
                the National Emergencies Act (50 U.S.C. 1622(d)), I am 
                continuing for 1 year the national emergency declared 
                in Executive Order 13405.

                This notice shall be published in the Federal Register 
                and transmitted to the Congress.
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

                THE WHITE HOUSE,

                    June 14, 2007.

[FR Doc. 07-3005
Filed 6-14-07; 12:01 pm]
Billing code 3195-01-P
Exhibit 31.2
 CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
      (a)
    
    Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under the Companys
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known to
us by others within those entities, particularly during the period in
which this report is being prepared;(b)
    
    Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under
the Companys supervision, to provide reasonable assurance regarding
the reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles;(c)
    
    Evaluated the effectiveness of the registrants disclosure controls
and procedures and presented in this report the Companys conclusions
about the effectiveness of the disclosure controls and procedures, as
of the end of the period covered by this report based on such
evaluation; and(d)
    
    Disclosed in this report any change in the registrants internal
control over financial reporting that occurred during the registrants
most recent fiscal quarter (the registrants fourth fiscal quarter in
the case of an annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal
control over financial reporting; and
  (a)
    
    All significant deficiencies and material
weaknesses in the design or operation of
internal control over financial reporting
which are reasonably likely to adversely
affect the registrants ability to record,
process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that
involves management or other employees who
have a significant role in the
registrants internal control over
financial reporting.
 /s/ Richard G. VasekRichard G. VasekChief Financial OfficerDate: April 14, 2009
    
    Principal Financial Officer
§ 77.07-1 Application. ( a ) The provisions of this subpart, with the exception of § 77.07-90, shall apply to all vessels contracted for on or after November 19, 1952. Vessels contracted for prior to November 19, 1952, shall meet the requirements of § 77.07-90.
( b ) [Reserved]
##### 



EXHIBIT 11 COMPUTER NETWORK TECHNOLOGY CORPORATION
Statement Re: Computation of Net loss Per Basic and Diluted shares
(in thousands, except per share data)
(Unaudited) Weighted Average
    
    Per shareNet loss
    
    Shares Outstanding
    
    AmountThree Months Ended April 30, 2004:Basic
    
    $
    (4,526
    )
    
    
    27,598
    
    
    $
    (.16
    )Dilutive effect of employee
awards and options and convertible notes(1)
    
    
    
    
    
    
    
    
    
    
    Diluted
    
    $
    (4,526
    )
    
    
    27,598
    
    
    $
    (.16
    )Three Months Ended April 30, 2003:Basic
    
    $
    (2,082
    )
    
    
    26,960
    
    
    $
    (.08
    )Dilutive effect of employee
awards and options and convertible notes(1)
    
    
    
    
    
    
    
    
    
    
    Diluted
    
    $
    (2,082
    )
    
    
    26,960
    
    
    $
    (.08
    )
 (1) Potential dilutive securities, consisting of convertible notes,
outstanding stock options and shares issuable under the employee stock
purchase plan, are excluded from the computation of diluted net loss per share
due to their anti-dilutive effect.
#### § 502.223 Decisions—Administrative law judges.

To the administrative law judges is delegated the authority to make and serve initial or recommended decisions. All initial and recommended decisions will include a statement of findings and conclusions, as well as the reasons or basis therefor, upon all the material issues presented on the record, and the appropriate rule, order, sanction, relief, or denial thereof. Where appropriate, the statement of findings and conclusions should be numbered. Initial decisions should address only those issues necessary to a resolution of the material issues presented on the record. A copy of each decision when issued shall be served on the parties to the proceeding. In proceedings involving overcharge claims, the presiding officer may, where appropriate, require that the carrier publish notice in its tariff of the substance of the decision. This provision shall also apply to decisions issued pursuant to subpart T of this part. [Rule 223.]

[64 FR 7810, Feb. 17, 1999]
<TABLE> <S> <C>

<ARTICLE> 5

<S>                                        <C>
<PERIOD-TYPE>                              12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                          154791
<SECURITIES>                                         0
<RECEIVABLES>                                   102846
<ALLOWANCES>                                         0
<INVENTORY>                                     377444
<CURRENT-ASSETS>                                758731
<PP&E>                                          248326
<DEPRECIATION>                                   76841
<TOTAL-ASSETS>                                 1201713
<CURRENT-LIABILITIES>                          1236562
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         10114
<OTHER-SE>                                      (60933)
<TOTAL-LIABILITY-AND-EQUITY>                   1201713
<SALES>                                        8737770
<TOTAL-REVENUES>                               8737770
<CGS>                                          7398134
<TOTAL-COSTS>                                  7398134
<OTHER-EXPENSES>                               1976672
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               22300
<INCOME-PRETAX>                                (659293)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                            (659293)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (659293)
<EPS-BASIC>                                   (0.066)
<EPS-DILUTED>                                   (0.066)


</TABLE>
EXHIBIT
32
 
 JACKSONVILLE
BANCORP, INC.
 Certification
Pursuant To 18 U.S.C. Section 1350,
 As
Enacted Pursuant To Section 906 of the Sarbanes-
 Oxley Act
of 2002
 
 
 In
connection with the Quarterly Report of Jacksonville Bancorp, Inc. (the
“Company”) on Form 10-QSB for the period ending March 31, 2005 as filed with the
Securities and Exchange Commission (the “Report”), the undersigned certify,
pursuant to 18 U.S.C. Section 1350, as enacted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:
 
 (1)
    The
      Report fully complies with the requirements of section 13(a) or 15(d) of
      the Securities Exchange Act of 1934; and
 (2)
    The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the Company
      as of and for the period covered by the
Report.
   Date:
      May 16, 2005
    
    /s/
      Gilbert J. Pomar, IIIGilbert J. Pomar, IIIPresident & Chief Executive
      OfficerDate:
      May 16, 2005
    
    /s/
      Valerie A. KendallValerie A. KendallChief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-1997
<PERIOD-START>                             JAN-01-1997
<PERIOD-END>                               JUN-30-1997
<CASH>                                         118,019
<INT-BEARING-DEPOSITS>                               0
<FED-FUNDS-SOLD>                               165,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                    191,886
<INVESTMENTS-CARRYING>                          29,260
<INVESTMENTS-MARKET>                            29,403
<LOANS>                                        848,272
<ALLOWANCE>                                     10,807
<TOTAL-ASSETS>                               1,910,330<F1>
<DEPOSITS>                                   1,197,578
<SHORT-TERM>                                    81,805
<LIABILITIES-OTHER>                            214,900
<LONG-TERM>                                    257,075
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                         7,586
<OTHER-SE>                                     138,755
<TOTAL-LIABILITIES-AND-EQUITY>               1,897,699<F1>
<INTEREST-LOAN>                                 39,715
<INTEREST-INVEST>                                7,143
<INTEREST-OTHER>                                19,020
<INTEREST-TOTAL>                                65,878
<INTEREST-DEPOSIT>                              17,273
<INTEREST-EXPENSE>                              27,442
<INTEREST-INCOME-NET>                           38,436
<LOAN-LOSSES>                                    3,700
<SECURITIES-GAINS>                                  57
<EXPENSE-OTHER>                                 42,367<F2>
<INCOME-PRETAX>                                 18,312
<INCOME-PRE-EXTRAORDINARY>                      18,312
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    11,428
<EPS-PRIMARY>                                     1.40
<EPS-DILUTED>                                     1.38
<YIELD-ACTUAL>                                    5.40
<LOANS-NON>                                     15,722
<LOANS-PAST>                                       346
<LOANS-TROUBLED>                                 8,228
<LOANS-PROBLEM>                                  2,023
<ALLOWANCE-OPEN>                                 9,333
<CHARGE-OFFS>                                    3,047
<RECOVERIES>                                       821
<ALLOWANCE-CLOSE>                               10,807
<ALLOWANCE-DOMESTIC>                             8,600
<ALLOWANCE-FOREIGN>                              1,000
<ALLOWANCE-UNALLOCATED>                          1,207
<FN>
<F1>Difference is minority interest in consolidated subsidiary of $12,631.
<F2>Does not include $1,021 of minority interest in net income of consolidated
subsidiary.
</FN>
        

</TABLE>
Release dates | Full version (300 KB PDF)Actions by the Board | Actions 
  under delegated authority
  Applications and reports:Boston
 |
New York
 |
Philadelphia
 |
Cleveland
 |
Richmond
 |
Atlanta
Chicago
 |
St. Louis
 |
Minneapolis
 |
Kansas City
 |
Dallas
 |
San Francisco

# District: 3
Federal Reserve Bank of: Philadelphia

## Filings received during the week ending October 11, 2008

|Filer | Filing Type | Filing Proposal | End of Comment Period
|----- | ----------- | --------------- | ---------------------
|NONE 

## Availability of CRA Public Evaluations

|Institution / Location | RSSDID | Exam Date | CRAPublic Date | CRARating | Exam Method
|---------------------- | ------ | --------- | -------------- | --------- | -----------
|NONE                  

## CRA Examinations scheduled for     Quarter of

|Institution | Location
|----------- | --------
|NONE       

* Subject to the provisions of the Community Reinvestment Act

Release dates | Full version (300 KB PDF)Actions by the Board | Actions 
  under delegated authority
  Applications and reports:Boston
 |
New York
 |
Philadelphia
 |
Cleveland
 |
Richmond
 |
Atlanta
Chicago
 |
St. Louis
 |
Minneapolis
 |
Kansas City
 |
Dallas
 |
San Francisco

---

Home Banking information and regulation  Accessibility Contact 
  us
## F IRST 

## D ISTRICT 

## C OURT OF 

## A PPEAL 

## S TATE OF 

## F LORIDA

_____________________________
No. 1D 18

- 2980

_____________________________
J OHN B ARNER , Appellant,

v.

S TATE OF F LORIDA , Appellee.

_____________________________

On appeal from the Circuit Court for Alachua County

. Mark W. Moseley , Judge

. August 16, 2019

P ER C URIAM

.
A FFIRMED

. B.L. T HOMAS and M.K. T HOMAS , J J
., and G AY , S HONNA Y OUNG , A SSOCIATE J UDGE , concur

.

_____________________________ Not final until disposition of any timely and authorized motion under Fla. R. App. P. 9.330 or 9.331

.

_____________________________2 John Barner, pro se
, Appellant.

Ashley Moody, Attorney General, and Sharon Traxler, Assist ant Attorney General, Tallahassee
, for Appellee.
§ 502.706 Request for an oral hearing or argument. ( a ) In the usual course of disposition of matters filed under this subpart, no oral hearing or argument will be held, but the administrative law judge, in their discretion, may order such hearing or argument.
( b ) A request for oral hearing or argument may be incorporated in the applicant or licensee's response or in the Bureau of Enforcement's reply to the response. Requests for oral hearing or argument will not be entertained unless they set forth in detail the reasons why the filing of affidavits or other documents will not permit the fair and expeditious disposition of the matter, and the precise nature of the facts sought to be proved or issues to be addressed at an oral hearing or argument.
( c ) The administrative law judge will rule upon a request for oral hearing or argument within ten (10) days of its receipt.
( d ) In the event oral hearing or argument is ordered, it will be held in accordance with the rules applicable to other formal proceedings, as set forth in subparts A through Q of this part. [Rule 706.]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended  (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Center for Complementary and Alternative Medicine Special Emphasis Panel Clinicl Studies.                    

*Date:*                         June 4-5, 2007.                    

*Time:*                         8 a.m. to 5:30 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015.                    

*Contact Person:*                         Jeanette M. Hosseini, Ph.D., Scientific Review Administrator, Office of Scientific Review, National Center for Complementary and Alternative Medicine, NIH, 6707 Democracy Blvd., Suite 401, Bethesda, MD 20892, (301) 594-9096,                         *jeanetteh@mail.nih.gov*.                    

Dated: May 1, 2007.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 07-2292 Filed 5-8-07; 8:45 am]

BILLING CODE 4140-01-M